|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
08-04-2010, 06:54 AM
|
|||
|
|||
Long-Term Follow-Up of DCVax-Treated Brain Cancer Patients Shows 33% of Patients Reac
BETHESDA, Md., Aug. 3 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) today announced further positive long-term follow-up data from its prior Phase I and Phase I/II clinical trials, in which patients with newly diagnosed Glioblastoma multiforme ("GBM"), the most rapid and lethal type of brain cancer, were treated with NWBT's DCVax ...
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| When To Deem Early Stage Lung Cancer Cured: Findings Help To Shape Long-Term Follow-U | cancerfr | Lung Cancer | 0 | 08-04-2010 05:23 PM |
| NWBT reports long-term follow-up data from DCVax-Brain immune therapy clinical trials | cancerfr | Brain Tumor | 0 | 08-04-2010 06:54 AM |
| Research findings help shape long-term follow-up strategies for early stage lung canc | cancerfr | Lung Cancer | 0 | 08-04-2010 06:54 AM |
| Less than Half of Breast Cancer Patients Follow Hormone Therapy | cancerfr | Oral Cancer | 0 | 06-29-2010 11:22 AM |
| Celsion Announces Long-Term Follow-Up Data From Phase 1 ThermoDox(R) Trial is Present | cancerfr | Adrenocortical Carcinoma | 0 | 04-16-2010 04:39 AM |
Linear Mode
